Effects of Spray and Stretch on Postneedling Soreness and Sensitivity After Dry Needling of a Latent Myofascial Trigger Point.

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
CEU San Pablo University
ClinicalTrials.gov Identifier:
NCT01608633
First received: May 27, 2012
Last updated: September 3, 2013
Last verified: September 2013

May 27, 2012
September 3, 2013
March 2012
April 2013   (final data collection date for primary outcome measure)
Pain [ Time Frame: 72 hours ] [ Designated as safety issue: No ]
Visual analogue scale
Same as current
Complete list of historical versions of study NCT01608633 on ClinicalTrials.gov Archive Site
  • Pain [ Time Frame: 48 hours ] [ Designated as safety issue: No ]
    Pressure pain threshold
  • Psychological factors [ Time Frame: 72 hours after needling ] [ Designated as safety issue: No ]
    Symptom check list revised. SCL-90-r
  • Pain [ Time Frame: 48 hours ] [ Designated as safety issue: No ]
    Pressure pain threshold
  • Psychological factors [ Designated as safety issue: No ]
    Symptom check list. SCL-90
Not Provided
Not Provided
 
Effects of Spray and Stretch on Postneedling Soreness and Sensitivity After Dry Needling of a Latent Myofascial Trigger Point.
Not Provided

Pain after dry needling or injection in the muscle is a frequent secondary effect in the treatment of myofascial pain syndrome. In this trial spray and stretch technique is evaluated as a method to reduce this soreness. As well, the characteristics and the different factors that influence in this pain will be described.

Not Provided
Interventional
Phase 2
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single Blind (Investigator)
Primary Purpose: Treatment
Pain After Dry Needling
Other: Spray and stretch
Physiotherapeutic technique which consist in stretching the muscle while a cold spray is applied on the skin.
  • Experimental: Spray and stretch
    Intervention: Other: Spray and stretch
  • No Intervention: Control
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
70
Not Provided
April 2013   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Subjects presenting latent trigger points in the trapezius muscle

Exclusion Criteria:

  • Subjects with active trigger points or absence of trigger points.
Both
18 Years to 65 Years
Yes
Contact information is only displayed when the study is recruiting subjects
Spain
 
NCT01608633
CEU-001
Not Provided
CEU San Pablo University
CEU San Pablo University
Not Provided
Not Provided
CEU San Pablo University
September 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP